tyrosine has been researched along with Cardiac Toxicity in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Evans, TRJ; Jones, R; Montezano, AC; Neves, KB; Rios, FJ; Touyz, RM | 1 |
Baram, SM; Dehpour, AR; Rahimian, R; Rahmatollahi, M; Saeedi Saravi, SS | 1 |
Ciccarelli, M; Del Pizzo, M; Iaccarino, G; Marzocco, S; Pecoraro, M; Pinto, A; Popolo, A; Sorrentino, R | 1 |
Agostinucci, K; Colton, HM; Dunn, ME; Engle, SK; Gallacher, M; Gropp, KE; King, NM; Manfredi, TG; More, V; Powe, J; Rodriguez, LA; Serra, D; Shimpi, P; Vetter, FJ | 1 |
4 other study(ies) available for tyrosine and Cardiac Toxicity
Article | Year |
---|---|
Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Cardiotoxicity; Cell Communication; Cell-Derived Microparticles; Cells, Cultured; Endothelial Cells; Endothelin-1; Female; Humans; Male; Middle Aged; Neoplasms; Nitric Oxide; Reactive Oxygen Species; Signal Transduction; Tyrosine; Vascular Endothelial Growth Factor A | 2019 |
Peroxisome Proliferator-Activated Receptor-α Inhibition Protects Against Doxorubicin-Induced Cardiotoxicity in Mice.
Topics: Animals; Atrial Function, Left; Benzoxazines; Cannabinoid Receptor Agonists; Cardiotonic Agents; Cardiotoxicity; Cytoprotection; Disease Models, Animal; Doxorubicin; Heart Diseases; Male; Malondialdehyde; Mice, Inbred BALB C; Morpholines; Myocardial Contraction; Myocytes, Cardiac; Naphthalenes; Oxazoles; PPAR alpha; Signal Transduction; Tumor Necrosis Factor-alpha; Tyrosine | 2016 |
Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity.
Topics: Animals; Antibiotics, Antineoplastic; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Echocardiography; Female; Interleukin-10; Interleukin-6; Mice, Inbred C57BL; Myocardium; Nitric Oxide Synthase Type II; Nitrites; Tumor Necrosis Factor-alpha; Tyrosine | 2016 |
Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy.
Topics: Animals; Biomarkers; Cardiotoxicity; Diagnosis, Differential; Hypertrophy, Left Ventricular; Male; Natriuretic Peptides; Oxazoles; PPAR gamma; Rats, Sprague-Dawley; Swimming; Tyrosine; Ventricular Function, Left; Ventricular Remodeling | 2017 |